Dow Down 0.17% Nasdaq Down 0.28%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
165.82 Down 2.13(1.27%) Sep 30, 4:00PM EDT
|After Hours : 165.82 0.00 (0.00%) Sep 30, 4:47PM EDT
Prev Close:167.95
Open:168.00
Bid:156.13 x 100
Ask:176.00 x 100
1y Target Est:198.65
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:164.41 - 168.28
52wk Range:100.89 - 185.43
Volume:1,285,799
Avg Vol (3m):1,110,140
Market Cap:32.80B
P/E (ttm):83.12
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNDown 1.27%32.80B
AMGNUp 0.28%106.69B
BAXDown 0.15%38.88B

Key Statistics

Forward P/E (1 yr):28.79
P/S (ttm):17.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback